EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease

Bence Sipos iD, Günter Klöppel

Endocrine-Related Cancer · 01.06.2023 · 30 (8)

DOI: 10.1530/erc-23-0032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 01.06.2023. Verfasst von Bence Sipos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tubingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Glucagon-Secreting Cells, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon cell hyperplasia and neoplasia (GCHN) is the name of an endocrine receptor disease, whose morphology was first described in 2006. Three years later, this rare disease was found to be to be caused by an inactivating mutation of the glucagon receptor ( GCGR ) gene. Functionally, the genetic defect mainly affects glucagon signaling in the liver with changes in the metabolism of glycogen, fatty acids and amino acids. Recent results of several studies in GCGR knockout mice suggested that elevated serum amino acid levels probably stimulate glucagon cell hyperplasia with subsequent transformation into glucagon cell neoplasia. This process leads over time to numerous small and some large pancreatic neuroendocrine tumors which are potentially malignant. Despite high glucagon serum levels, the patients develop no glucagonoma syndrome. In 2015, GCHN was identified as an autosomal recessive hereditary disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Secreting CellsNeoplasmsAnimalsMiceGlucagonHyperplasiaReceptors, GlucagonHumans

Stichwörter der Autor:innen

glucagon cell hyperplasia and neoplasiahyperglucagonemiamultiple pancreatic neuroendocrine tumors

Substanzen

GlucagonReceptors, Glucagon

Autor:innen und Institutionen

  • Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tubingen, Tübingen, Germany.
  • ENETS Center of Excellence, University Hospital Tübingen, Tübingen, Germany.
  • Department of Pathology, Technical University Munich, Munich, Germany.

ORCID-Profile: Bence Sipos

Zitieren

APA

Sipos, B., & Klöppel, G. (2023). Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease. Endocrine-Related Cancer, 30(8). https://doi.org/10.1530/erc-23-0032

Vancouver

Sipos B, Klöppel G. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease. Endocrine-Related Cancer. 2023;30(8). doi:10.1530/erc-23-0032

BibTeX
@article{Sipos2023,
  author = {Sipos, Bence and Klöppel, Günter},
  title = {Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  volume = {30},
  number = {8},
  doi = {10.1530/erc-23-0032}
}
Kostenlos starten →